Montgomery Mutual Insurance v. Chesson

923 A.2d 939, 399 Md. 314, 2007 Md. LEXIS 331
CourtCourt of Appeals of Maryland
DecidedMay 23, 2007
Docket110, September Term, 2006
StatusPublished
Cited by34 cases

This text of 923 A.2d 939 (Montgomery Mutual Insurance v. Chesson) is published on Counsel Stack Legal Research, covering Court of Appeals of Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Montgomery Mutual Insurance v. Chesson, 923 A.2d 939, 399 Md. 314, 2007 Md. LEXIS 331 (Md. 2007).

Opinion

RAKER, J.

This appeal arises from a final judgment in a workers’ compensation matter in which a jury in the Circuit Court for Howard County returned a verdict in favor of respondents and against the Baltimore Washington Conference of the United Methodist Church and Montgomery Mutual Insurance Company. Respondents claimed that they each had sustained an accidental injury or occupational disease, known as “sick building syndrome,” 1 arising out of and in the course of their *318 employment, due to exposure to toxic mold. The issue presented in this case is whether the Circuit Court abused its discretion by not holding a Frye-Reed hearing pursuant to our holding in Reed v. State, 283 Md. 374, 391 A.2d 364 (1978), to determine the admissibility of the testimony of respondents’ expert, Ritchie Shoemaker, M.D., and specifically, to decide whether the doctor’s methodologies used for diagnosis and theories regarding the causal connection between mold exposure and certain human health effects are generally accepted in the scientific community for that purpose. We shall hold that the expert’s testimony should have been the subject of a Frye-Reed hearing.

I.

Respondents, Josephine Chesson, Martha Knight, Carole Silberhorn, Linda Gamble, Kenneth Lyons, and Connie Collins, were employees of the Baltimore Washington Conference of the United Methodist Church, and worked at the Church’s offices located at 9720 Patuxent Woods Parkway, Columbia, Maryland. On November 18, 2002, several employees working in the office building noticed a foul odor emanating from the walls. A maintenance crew broke through an interior wall and discovered two types of mold, Aspergillus and Stachybotrys.

Respondents each filed a claim with the Maryland Worker’s Compensation Commission, alleging that they had sustained an accidental injury or occupational disease known as sick building syndrome due to mold exposure on November 18, 2002. See Md.Code (1999, 2006 Cum.Supp.) § 9-101 et seq. of the Labor and Employment Article. The Workers’ Compensation Commission held a hearing and disallowed two of respondents’ claims and awarded partial compensation to the remaining respondents after finding accidental injury or occupational disease due to mold exposure. 2 Each respondent *319 filed a petition for judicial review in the Circuit Court for Howard County, see Md.Code (1999, 2006 Cum.Supp.) § 9-737 et seq. of the Labor and Employment Article, and a joint motion to consolidate the claims.

The Circuit Court consolidated the claims. 3 Each respondent had been examined and treated by Dr. Ritchie Shoemaker, a licensed medical doctor and board-certified physician in the field of family medicine. Prior to trial, petitioner filed a motion in limine seeking to exclude the testimony of Dr. Shoemaker on the grounds that his theories and methodologies for diagnosis regarding a causal connection between mold exposure and certain human health effects had not been generally accepted within the relevant scientific community. Petitioner requested a Frye-Reed hearing, addressing the court as follows:

“[DEFENSE COUNSEL]: The diagnosis of sick building syndrome, or bio toxic illness, assumes the causal relationship of the symptoms, to the bio toxic illness. It’s — the diagnosis in itself, of the bio toxic illness, is that this particular illness exists, as a legitimate illness. Unfortunately, the ICD-9 classifications, which lists all diagnosis, for all illnesses, do not recognize bio toxic illness as an illness. It’s also not recognized by the CDC, the Institute of Medicine, and NIOSH, The National Institute of Occupational Safety and Health.
Arrival at that diagnosis of bio toxic illness, uses techniques not generally accepted by the scientific community, which is the Frye-Reed test.
Dr. Shoemaker focuses on a constellation of symptoms as being caused by bio toxic illness. This constellation of symptoms is not accepted as an illness from mold. The *320 fundamental principles of differential diagnosis require that you rule out other causes of illnesses from symptoms that are presented from the patient. The first thing you would do is rule out known illnesses, not an illness that you happen to have made up yourself, and that is not accepted by the ICD-9 classifications. For example, the symptoms presented by these claimants could include: allergic rhinitis, sinusitis, stress at the belief of being ill; those illnesses were not even considered by Dr. Shoemaker. He took the constellation—
THE COURT: Excuse me, wouldn’t that go to the weight, rather than the admissibility of his opinion?
[DEFENSE COUNSEL]: No, because you must base your opinion on accepted medical and scientific data. Using a constellation of symptoms, and concluding that it’s sick building syndrome, is not a generally accepted method for diagnosis. The generally accepted method for diagnosis is to rule out different illnesses that are accepted as illnesses. In addition, accepting a patient’s prior medical history just by having them tell you, -without verifying the accuracy of the information, is not a generally accepted form of diagnosis. Dr. Shoemaker, by his own admission, reviewed no medical evidence, whatsoever, concerning prior illnesses. In addition, he prescribes a drug, Cholestyramine, for the treatment of bio toxic illness, and the FDA has not approved Cholestyramine for the treatment of bio toxic illness because, of course, they don’t recognize bio toxic illness as a legitimate illness.
The modifying of the accepted diagnostic tools, also comes under a Frye-Reed evaluation, and that is exactly what Dr. Shoemaker is doing. He’s saying, look there’s five thousand tests of the visual-contrast sensitivity test. There’s, you know, four thousand studies on Cholestyramine, but what he is not telling you, is that those studies are being modified for his use; his use is unique, and new, it’s a new scientific technique and it should be looked at under the Frye-Reed test.
*321 When we look at these issues with diagnosis and treatment, we haven’t even gotten yet to his expression of ‘causal relationship.’ If he can separate out where he has diagnosis, and then goes to ‘causal relationship,’ I’d sure like to see it, because by the time these people even got to him, he had already diagnosed sick building syndrome. He sent out the questionnaires, they filled them out, and sent them back, or brought them back and, by that time, he found sick building syndrome. He didn’t do any differential diagnosis, even though he says he did.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Williams v. State
Court of Special Appeals of Maryland, 2021
Matthews v. State
246 A.3d 644 (Court of Special Appeals of Maryland, 2021)
Rochkind v. Stevenson
236 A.3d 630 (Court of Appeals of Maryland, 2020)
Portillo Funes v. State
230 A.3d 121 (Court of Appeals of Maryland, 2020)
Burks v. Allen
192 A.3d 847 (Court of Special Appeals of Maryland, 2018)
Sissoko v. State
182 A.3d 874 (Court of Special Appeals of Maryland, 2018)
Commonwealth v. Jacoby, T., Aplt.
170 A.3d 1065 (Supreme Court of Pennsylvania, 2017)
Savage v. State
166 A.3d 183 (Court of Appeals of Maryland, 2017)
Rockman v. Union Carbide Corp.
266 F. Supp. 3d 839 (D. Maryland, 2017)
Attorney Grievance Commission v. Chanthunya
133 A.3d 1034 (Court of Appeals of Maryland, 2016)
Roy v. Dackman
124 A.3d 169 (Court of Appeals of Maryland, 2015)
Stevenson v. State
112 A.3d 959 (Court of Special Appeals of Maryland, 2015)
Carter v. Wallace & Gale Asbestos Settlement Trust
96 A.3d 147 (Court of Appeals of Maryland, 2014)
Chesson v. Montgomery Mutual Insurance
75 A.3d 932 (Court of Appeals of Maryland, 2013)
Dixon v. Ford Motor Co.
70 A.3d 328 (Court of Appeals of Maryland, 2013)
Exxon Mobil Corp. v. Albright
71 A.3d 30 (Court of Appeals of Maryland, 2013)
Montgomery Mutual Insurance v. Chesson
51 A.3d 18 (Court of Special Appeals of Maryland, 2012)
Wilkerson v. State
24 A.3d 703 (Court of Appeals of Maryland, 2011)
State v. Walker
11 A.3d 811 (Court of Appeals of Maryland, 2011)
Addison v. State
981 A.2d 698 (Court of Special Appeals of Maryland, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
923 A.2d 939, 399 Md. 314, 2007 Md. LEXIS 331, Counsel Stack Legal Research, https://law.counselstack.com/opinion/montgomery-mutual-insurance-v-chesson-md-2007.